Glp-1

GLP-1, or glucagon-like peptide-1, is a key hormone that plays a significant role in glucose metabolism and appetite regulation. As an incretin hormone, GLP-1 is secreted in response to food intake, stimulating insulin secretion while inhibiting glucagon release from the pancreas, effectively lowering blood sugar levels. Recent studies highlight its potential in weight management, making it a focus of many obesity treatments. Clinical trials have shown that GLP-1 receptor agonists, like liraglutide and semaglutide, not only help in glycemic control for type 2 diabetes but also promote significant weight loss. These medications mimic the effects of GLP-1 and are administered via injections or oral formulations. Moreover, the long-term effects and safety of GLP-1 therapies are being researched extensively, providing insights on their role in cardiovascular health. Understanding the mechanisms of GLP-1 can aid in appreciating its significance in metabolic health, and how it could be integrated into treatment plans for individuals struggling with diabetes and obesity.